Page last updated: 2024-11-12
pentaborane
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 15764013 |
MeSH ID | M0123273 |
Synonyms (15)
Synonym |
---|
BIDD:ER0069 |
pentaborane |
19624-22-7 |
65580-80-5 |
(-)-epn |
unii-3qp6ts3ga2 |
ethyl p-nitrophenyl benzenethiophosphonate, (-)- |
phosphonothioic acid, phenyl-, o-ethyl o-(4-nitrophenyl) ester, (-)- |
3qp6ts3ga2 , |
phosphonothioic acid, phenyl-, o-ethyl o-(4-nitrophenyl) ester, (s)- |
phosphonothioic acid, p-phenyl-, o-ethyl o-(4-nitrophenyl) ester, (p(s))- |
phosphonothioic acid, phenyl-, o-ethyl o-(4-nitrophenyl) ester, (p(s))- |
(-)-ethyl p-nitrophenyl benzenethiophosphonate |
Q27257910 |
ethoxy-(4-nitrophenoxy)-phenyl-sulfanylidene-lambda5-phosphane |
Research Excerpts
Overview
Pentaborane is an extremely toxic compound and a major hazard not only to exposed workers but also to the medical personnel dealing with them.
Excerpt | Reference | Relevance |
---|---|---|
"Pentaborane is an extremely toxic compound and a major hazard not only to exposed workers but also to the medical personnel dealing with them." | ( Severe central nervous system damage and profound acidosis in persons exposed to pentaborane. Cooper, KR; Garrettson, LK; Kelleher, AB; Steele, MH; Yarbrough, BE; Zolet, DI, ) | 1.08 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (19)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 17 (89.47) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (10.53) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 39.42
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (39.42) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (5.00%) | 6.00% |
Case Studies | 1 (5.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 18 (90.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |